These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14656381)

  • 1. FGF signaling inhibits the proliferation of human myeloma cells and reduces c-myc expression.
    Firme L; Bush AB
    BMC Cell Biol; 2003 Dec; 4():17. PubMed ID: 14656381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant downregulation of proliferation/survival pathways dependent on FGF-R3, JAK2 and BCMA in human multiple myeloma cells by multi-kinase targeting.
    Cassinelli G; Ronchetti D; Laccabue D; Mattioli M; Cuccuru G; Favini E; Nicolini V; Greco A; Neri A; Zunino F; Lanzi C
    Biochem Pharmacol; 2009 Nov; 78(9):1139-47. PubMed ID: 19555670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron specific growth inhibition of Burkitt's lymphoma cells in vitro, associated with a decrease in translocated c-myc expression.
    Habel ME; Lemieux R; Jung D
    J Cell Physiol; 2005 Apr; 203(1):277-85. PubMed ID: 15468060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F; Ciccarelli C; Zani BM
    Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy.
    Ishibe T; Nakayama T; Okamoto T; Aoyama T; Nishijo K; Shibata KR; Shima Y; Nagayama S; Katagiri T; Nakamura Y; Nakamura T; Toguchida J
    Clin Cancer Res; 2005 Apr; 11(7):2702-12. PubMed ID: 15814652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of Akt activity contributes to the growth arrest induced by FGF in chondrocytes.
    Priore R; Dailey L; Basilico C
    J Cell Physiol; 2006 Jun; 207(3):800-8. PubMed ID: 16523491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crucial role of phosphatase CD45 in determining signaling and proliferation of human myeloma cells.
    Collette M; Descamps G; Pellat-Deceunynck C; Bataille R; Amiot M
    Eur Cytokine Netw; 2007 Sep; 18(3):120-6. PubMed ID: 17823079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of c-Kit isoforms in multiple myeloma: differences in signaling and drug sensitivity.
    Montero JC; López-Pérez R; San Miguel JF; Pandiella A
    Haematologica; 2008 Jun; 93(6):851-9. PubMed ID: 18443272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant translational control of the c-myc gene in multiple myeloma.
    Paulin FE; West MJ; Sullivan NF; Whitney RL; Lyne L; Willis AE
    Oncogene; 1996 Aug; 13(3):505-13. PubMed ID: 8760292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Myc protein is stabilized by fibroblast growth factor 2 and destabilized by ACTH to control cell cycle in mouse Y1 adrenocortical cells.
    Lepique AP; Moraes MS; Rocha KM; Eichler CB; Hajj GN; Schwindt TT; Armelin HA
    J Mol Endocrinol; 2004 Dec; 33(3):623-38. PubMed ID: 15591023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the growth inhibition of human multiple myeloma cells by an IL-6Ralpha mutant.
    Duan J; Cai X; Wang L; Zhang S; Wang J
    IUBMB Life; 2000 Jan; 49(1):23-5. PubMed ID: 10772337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated proliferation of myeloma cells by interleukin-6 cooperating with fibroblast growth factor receptor 3-mediated signals.
    Ishikawa H; Tsuyama N; Liu S; Abroun S; Li FJ; Otsuyama K; Zheng X; Ma Z; Maki Y; Iqbal MS; Obata M; Kawano MM
    Oncogene; 2005 Sep; 24(41):6328-32. PubMed ID: 15940250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress.
    Ronca R; Ghedini GC; Maccarinelli F; Sacco A; Locatelli SL; Foglio E; Taranto S; Grillo E; Matarazzo S; Castelli R; Paganini G; Desantis V; Cattane N; Cattaneo A; Mor M; Carlo-Stella C; Belotti A; Roccaro AM; Presta M; Giacomini A
    Cancer Res; 2020 Jun; 80(11):2340-2354. PubMed ID: 32094301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt/beta-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC.
    Yang F; Zeng Q; Yu G; Li S; Wang CY
    Cell Signal; 2006 May; 18(5):679-87. PubMed ID: 16084063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [5-azacytidine treatment induces tumor suppressor gene XAF1 expression and inhibits proliferation in myeloma cells].
    Chen GH; Lin FR; Wu DP; Wang Y; Huang HW; Tang XW; Zhu ZL; Feng YF; Chang WR
    Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):229-32. PubMed ID: 19731821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species.
    Nakazato T; Ito K; Ikeda Y; Kizaki M
    Clin Cancer Res; 2005 Aug; 11(16):6040-9. PubMed ID: 16115949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of fibroblast growth factors and their receptors in prostate cancer.
    Kwabi-Addo B; Ozen M; Ittmann M
    Endocr Relat Cancer; 2004 Dec; 11(4):709-24. PubMed ID: 15613447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor-2 over-rides insulin-like growth factor-I induced proliferation and cell survival in human neuroblastoma cells.
    Russo VC; Andaloro E; Fornaro SA; Najdovska S; Newgreen DF; Bach LA; Werther GA
    J Cell Physiol; 2004 Jun; 199(3):371-80. PubMed ID: 15095284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
    Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
    Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
    Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
    Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.